T1	Outcomes 34 65	anti-IgE-induced skin reactions
T2	Outcomes 790 801	wheal areas
T3	Outcomes 807 828	significantly reduced
T4	Outcomes 989 1005	oedema formation
T5	Outcomes 1168 1182	skin reactions
